NCT05151874

Valuation of the Evolution of Passive Mobility in the Spastic Upper Limb After Injection of Abobotulinumtoxin(Dysport®)

Valuation of the Evolution of Passive Mobility (ROM)in the Spastic Upper Limb After Injection of Abobotulinumtoxin(Dysport®) in Patients With Post-stroke Spasticity

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 12 (estimated)
• Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

Assessing the objective measurement of passive joint mobility (ROM) in the spastic upper limb with Jost's pattern III in patients with post-stroke spasticity after infiltration with BoNT-A allows to objectify the increase in passive joint balance (ROM).

Detailed description

Changes in joint mobility in patients with post-stroke upper limb spasticity after infiltration of botulinum toxin type A. The spasticity pattern that will be evaluated will be pattern number III based on the classification of Jost et al. Joint mobility will be measured with the Lynx instrument (DyCare)

Conditions

• Spasticity, Muscle
• Stroke Sequelae
• Movement Disorders

Interventions

Type	Name	Description
DRUG	Abobotulinum toxin A	To measure ROM evolution in patients with post-stroke spasticity in the upper limb with spasticity pattern III.

Timeline

• Start date: 2022-01-01
• Primary completion: 2022-12-01
• Completion: 2022-12-01
• First posted: 2021-12-09
• Last updated: 2021-12-09

Locations

1 site across 1 country: Spain